Boothbay Fund Management’s Immunovant IMVT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Hold |
0
| – | – | – | 1384 |
|
|
2025
Q1 | – | Hold |
0
| – | – | – | 1399 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 1505 |
|
|
2024
Q3 | – | Sell |
-64,796
| Closed | -$1.71M | – | 1563 |
|
|
2024
Q2 | $1.71M | Sell |
64,796
-221
| -0.3% | -$5.83K | 0.04% | 469 |
|
|
2024
Q1 | $2.1M | Buy |
65,017
+15,427
| +31% | +$498K | 0.04% | 406 |
|
|
2023
Q4 | $2.09M | Sell |
49,590
-5,516
| -10% | -$232K | 0.05% | 384 |
|
|
2023
Q3 | $2.12M | Buy |
+55,106
| New | +$2.12M | 0.05% | 386 |
|
|
2023
Q2 | – | Sell |
-138,000
| Closed | -$2.14M | – | 1776 |
|
|
2023
Q1 | $2.14M | Sell |
138,000
-38,388
| -22% | -$595K | 0.04% | 524 |
|
|
2022
Q4 | $3.13M | Buy |
176,388
+34,253
| +24% | +$608K | 0.07% | 333 |
|
|
2022
Q3 | $793K | Buy |
+142,135
| New | +$793K | 0.02% | 875 |
|
|
2021
Q4 | – | Sell |
-32,233
| Closed | -$280K | – | 1832 |
|
|
2021
Q3 | $280K | Sell |
32,233
-12,726
| -28% | -$111K | 0.01% | 1142 |
|
|
2021
Q2 | $475K | Buy |
+44,959
| New | +$475K | 0.02% | 901 |
|
|
2021
Q1 | – | Sell |
-28,568
| Closed | -$1.32M | – | 1424 |
|
|
2020
Q4 | $1.32M | Sell |
28,568
-10,464
| -27% | -$483K | 0.05% | 332 |
|
|
2020
Q3 | $1.37M | Buy |
39,032
+3,525
| +10% | +$124K | 0.08% | 277 |
|
|
2020
Q2 | $865K | Sell |
35,507
-84,097
| -70% | -$2.05M | 0.06% | 362 |
|
|
2020
Q1 | $1.86M | Buy |
119,604
+34,941
| +41% | +$544K | 0.15% | 138 |
|
|
2019
Q4 | $1.34M | Sell |
84,663
-351,601
| -81% | -$5.58M | 0.12% | 203 |
|
|
2019
Q3 | $4.33M | Buy |
+436,264
| New | +$4.33M | 0.4% | 33 |
|